Inventor
MOE GREGORY R
US19 patents
⚠️ This page may combine multiple inventors who share the name “MOE GREGORY R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MOE GREGORY R
7 patentsUS8642562B2Feb 4, 2014
Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
MOE GREGORY R6 citations80
US8148335B2Apr 3, 2012
De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
MOE GREGORY R9 citations80
US9333247B2May 10, 2016
Oligosialic acid derivatives, methods of manufacture, and immunological uses
MOE GREGORY R3 citations69
US9089513B2Jul 28, 2015
De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
MOE GREGORY R2 citations59
US8642733B2Feb 4, 2014
T-cell stimulating protein B and methods of use
MOE GREGORY R0 citations51
US8097591B2Jan 17, 2012
Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
MOE GREGORY R0 citations48
US8999954B2Apr 7, 2015
Inhibitors of polysialic acid de-N-acetylase and methods for using the same
MOE GREGORY R0 citations38
CHIRON CORP
3 patentsUS6048527AApr 11, 2000
Antibodies that define unique Meningococcal B epitopes and vaccine compositions
CHIRON CORP61 citations96
US6030619AFeb 29, 2000
Molecular mimetics of meningococcal B epitopes
CHIRON CORP33 citations92
US6642354B2Nov 4, 2003
Molecular mimetics of unique Neisseria meningitidis serogroup B epitopes
CHIRON CORP9 citations73
CHILDRENS HOSPITAL & RES CENTER AT OAKLAND
2 patentsUS11065341B2Jul 20, 2021
DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
CHILDRENS HOSPITAL & RES CENTER AT OAKLAND0 citations59
US10576137B2Mar 3, 2020
Oligosialic acid derivatives, methods of manufacture, and immunological uses
CHILDRENS HOSPITAL & RES CENTER AT OAKLAND0 citations49